- AdventHealth Research Institute
A new study reveals that people newly diagnosed with Type 2 diabetes face a significantly higher risk of developing aggressive cancers—including those of the liver, pancreas, and colon.
While obesity has long been linked to these cancers, the research suggests Type 2 diabetes itself may be an independent driver of cancer risk. The findings, presented at the 2025 European Congress on Obesity, analyzed data from over 23,000 people in the U.K. Biobank with new-onset Type 2 diabetes and compared them to more than 71,000 non-diabetic individuals of similar age, sex, and weight.
Over five years, cancer risk was clearly higher in the diabetes group:
- Liver cancer risk was nearly 4 times higher in men and 5 times higher in women.
- Pancreatic cancer risk rose 74% in men, nearly doubled in women.
- Colorectal cancer risk increased by more than 25% in both groups.
Lead author Owen Tipping from the University of Manchester said the link may stem from factors like inflammation, insulin resistance, or gut microbiome changes—beyond just excess weight.
Experts say more research is needed but agree the findings highlight the importance of early detection, healthy lifestyle changes, and ongoing monitoring. “This isn’t a reason to panic,” said oncologist Dr. Jack Jacoub. “It’s a reason to take action—through diet, exercise, and good blood sugar control.”
The takeaway? Type 2 diabetes may do more than disrupt blood sugar—it could quietly raise your cancer risk too.
Recent News
AdventHealth Research Institutes own Dr. Kirk Erickson was recently featured on Fox 35 to talk about the connection between physical activity and brain health.
In our latest Clinician’s View, Dr. Patel shares his team’s telesurgery journey, including how they are ensuring safety, quality and ethical exploration of this innovative approach.
Starting school is exciting and for families managing T1D, a little planning can make all the difference.
We’re proud to announce that Stephanie Compton, PhD, a valued post‑doctoral researcher at the AdventHealth Research Institute, was recently featured by the American Cancer Society.
The adventHealth is excited to announce the launch of the SOMMA study. This study aims to better understand how our muscles and mobility function change as we age.
We are proud to announce the launch of the new RISE study.
Dr. Iswanto Sucandy was recently featured on AdventHealth West Florida Division’s “Team Talk” to discuss his groundbreaking textbook.
AdventHealth Research Institute’s new review, authored by Drs. Katie Whytock and Bret Goodpaster and published in Circulation Research, highlights how skeletal muscle regulates insulin and glucose...
On July 10, 2025, AdventHealth Director of Neuroscience Clinical Research Anita Fletcher, MD, worked with NKGen Biotech to administer the first dose of troculeucel (SNK01), an investigative natural...
In our latest Clinician’s View, Dr. Seminerio shares her personal passion for improving care for patients with inflammatory bowel disease (IBD) and talks about how AdventHealth’s recently established...
Under the leadership of Principal Investigator Valeria Baldivieso, MD, and Sub-Investigator Chandan Reddy, MD, MS, FAANS, the AdventHealth Research Institute is recruiting patients for the Exablate...
New Study Published in the New England Journal of Medicine Shows the Addition of Regional Nodal Irradiation Does Not Decrease Rate of Invasive Breast Cancer Recurrence in Patients with Negative...